Skip Links

drug life cycle

Path to a new medicine

The discovery, development and commercialisation of a medicine is a complex process. This is a high level overview of the process for a new small molecule medicine. It is illustrative only. It is not intended to (and nor does it) represent the life-cycle of any particular medicine or of every medicine discovered and/or developed by AstraZeneca.

Strategy and
Performance

strategy

"The executive team ... believes that the most value-creating strategy for AstraZeneca is to remain a focused, integrated, innovation-driven, global, prescription-based biopharmaceutical business."

Find out more

Download
Report

AstraZeneca Annual Report and Form 20-F Information 2009

English (PDF 5.8Mb)
Swedish (PDF 3.3Mb)